JP Morgan Maintains Overweight on IDEAYA Biosciences, Lowers Price Target to $66
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Anupam Rama maintains an Overweight rating on IDEAYA Biosciences (NASDAQ:IDYA) but lowers the price target from $69 to $66.
August 08, 2024 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan analyst Anupam Rama maintains an Overweight rating on IDEAYA Biosciences but lowers the price target from $69 to $66.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some tempered expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100